OpenArc Corporate Advisory’s Pharvaris PHVS Stock Holding History

OpenArc Corporate Advisory’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Buy	+13,595	New	+$411K	0.01%	506

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

OpenArc Corporate Advisory's PHVS Position: Q2 2026 in Review

OpenArc Corporate Advisory opened a new position in Pharvaris (PHVS) in Q2 2026: 13,595 shares worth $470K. The stake represents 0.01% of the portfolio and ranks #506 among its holdings.

125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

OpenArc Corporate Advisory held 13,595 shares of Pharvaris worth $470K as of Q2 2026.
Pharvaris was a new OpenArc Corporate Advisory position in Q2 2026.
Pharvaris made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #506 holding.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.